Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

• Published in: PLoS Neglected Tropical Diseases
• Main Authors: Christian Schaetti, Mitchell G Weiss, Said M Ali, Claire-Lise Chaignat, Ahmed M Khatib, Rita Reyburn, Radboud J Duintjer Tebbens, Raymond Hutubessy
• Format: Article in Journal/Newspaper
• Language: English
• Published: Public Library of Science (PLoS) 2012
• Subjects: Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270; Arctic; Daly
• Online Access: https://doi.org/10.1371/journal.pntd.0001844; https://doaj.org/article/5120a055b1db49a3bc1de60a1b2dfe60

BACKGROUND: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplementary tool to conventional prevention of cholera. Dukoral, a killed whole-cell two-dose OCV, was used in a mass vaccination campaign in 2009 in Zanzibar. Public and private costs of illness (COI) due...